Thank you for calling attention to the physician-pharma association in the article I had cited in a previous post – https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995199/ – but first, I’d like to extend a warm welcome to you and sincerely look forward to getting to know you better, as and when you are able to share more about yourself.
You are absolutely correct in saying, “…you should be completely transparent in the information that you are posting, particularly as moderator of this forum.”
As a moderator, I want to communicate in a clear and professional way each time I put something in public view – it is a reflection of myself, of the community, and of course, my employer. But, I would be remiss not to mention a few observations:
1) When manuscripts are accepted, disclosures of conflict of interest, relevant financial interests, activities, relationships, and affiliations, for each of the authors are published in the Acknowledgment section of the article, or the Biography section of the article…and thereby disclosed to readers.
**With regard to the author of the article in question – Dr. Pandolfino (Chief of Gastroenterology and Hepatology, Professor of Medicine, Northwestern University) – the exact disclosure(s) is clearly stated under “Footnotes” in the Biography section of the article.
**I thought – and am still of the opinion – that the inclusion of such statement/footnote suffices for transparency. However, if I were citing an article authored/published by Mayo Clinic, I would be certain to specifically mention any external association in my post.
2) PubMed Central® (PMC – the ‘resource' for the article) is an archive of biomedical and life sciences journal literature at the U.S. National Institutes of Health's National Library of Medicine (NIH/NLM). The presence of an article does not reflect an endorsement of, or concurrence with, the contents of the article.
**Gastroenterology and Hepatology journal publishes peer-reviewed original papers, metaanalyses, systematic reviews, and editorials concerned with clinical practice and research in the fields of hepatology, gastroenterology and endoscopy. It is one of several reliable and authoritative resources for GI-related interest groups – on par with the New England Journal of Medicine (NEJM), which includes variety of medical-interest groups.
3) As you correctly stated, M. Brian Fennerty, M.D. is "a doctor unaffiliated with any Pharma companies and the founding editor of NEJM's Journal Watch.” But might I request you to keep in mind that this standard applies solely to the ‘editors’; and not to ‘authors’.
"No NEJM editor is permitted to have any financial relationship with any biomedical company.” https://www.nejm.org/media-center/integrity-safeguards
**Here again, I thought you might wish to read about Dr. Fennerty’s disclosures and association with pharmaceutical companies, prior to his role as editor:
– https://www.medscape.org/viewarticle/457393_3M Brian Fennerty, MD
M. Brian Fennerty, MD, Professor, Section Chief of Gastroenterology, Oregon Health Sciences University
Disclosure: Consultant/Speakers Bureau: AstraZeneca, TAP, Wyeth;
Research Grants: AstraZeneca, Eisai Inc, Janssen Pharmaceutica
@eleanorm, our community members should feel safe, which is why we monitor the conversations AND rely on community members like yourself to report if you felt anything was amiss – I hope this (very long) explanation is helpful.
You can also read more about why and how we moderate on Connect: https://connect.mayoclinic.org/about-our-moderators-and-mentors/ Please don’t hesitate to connect with me:) with any further questions or concerns; I do look forward to hearing from you.